Over-the-counter medication and herbal or dietary supplement use in college: Dose frequency and relationship to self-reported distress

Journal of American College Health

Volumn 56, Issue 5, 2008, Pages 535-548

  Stasio, Michael J ^a   Curry, Kim ^a   Sutton Skinner, Kelly M ^b   Glassman, Destinee M ^a  

^a UNIVERSITY OF TAMPA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

College students; Distress; Herbs; Over the counter; Supplements

Indexed keywords

EID: 42349103630     PISSN: 07448481     EISSN: None     Source Type: Journal    
DOI: 10.3200/JACH.56.5.535-548     Document Type: Article

References (34)

1. Kennedy J. Herb and supplement use in the US adult population. Clin Ther. 2005;27:1847-1858.
2. Yussman SM, Wilson KM, Klein, JD. Herbal products and their association with substance use in adolescents. J Adolesc Health. 2006;38:395-400.
3. Stein RA, Strickland TL. A review of neuropsychological effects of commonly used prescription medications. Arch Clin Neuropsychol. 1998;13:259-284.
4. Mochizuki H, Tashiro M, Tagawa M, et al. The effects of a sedative anithistamine, d-chlorheniramine, on visual spatial discrimination and regional brain activity as measured by positron emission tomography (PET). Hum Psychopharmacol. 2002;17:413-418.
5. Newberry H, Beerman K, Duncan S, McGuire M, Hillers V. Use of nonvitamin, nonmineral dietary supplements among college students. J Am Coll Health. 2001;50:121-129.
6. American College Health Association. Healthy Campus 2010. http://www.acha.org/info_resources/hc2010.cfm. Accessed August 6, 2006.
7. American College Health Association. American College Health Association National College Health Assessment (ACHA-NCHA) spring 2005 reference group data report (abridged). J Am Coll Health. 2005;55:5-16.
8. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry. 2004;61:807-816.
9. Mischoulon D. The herbal anxiolytics kava and valerian for anxiety and insomnia. Psychiatric Ann. 2002;32:55-74.
10. Singh YN, Singh NN. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs. 2002;16:731-743.
11. US Food and Drug Administration Center for Drug Evaluation and Research. Office of Nonprescription Products Web site. http://www.fda.gov/cder/Offices/ OTC/default.htm. Accessed August 6, 2006.
12. Rizzo JA. Prescription to over-the-counter switching of drugs. Dis Manag Health Outcomes. 2005;13:83-92.
13. Shader RI, Greenblatt DJ. The safety of over-the-counter drugs: some reflections and unanswered questions. J Clin Psychopharmacol. 2003;23:111-112.
14. Lo A. Patient characteristics associated with nonprescription drug use in intentional overdose. Can J Psychiatry. 2005;48:232-236.
15. Burak LJ, Damico A. College students' use of widely advertised medications. J Am Coll Health. 2000;49:118-120.
16. Steinman KJ. High school students' misuse of over-the-counter drugs: a population-based study in an urban county. J Adolesc Health. 2006;38:445-447.
17. Wazaify M, Shields E, Hughes CM, et al. Societal perspectives on over-the-counter (OTC) medicines. Family Practice. 2005;22:170-176.
18. Howland J, Weinberg J, Smith E, et al. Prevalence of allergy symptoms and associated medication use in a sample of college seniors. J Am Coll Health. 2002;51:67-70.
19. Simons L, Klichine S, Lantz V, et al. The relationship between social-contextual factors and alcohol and polydrug use among college freshmen. J Psychoactive Drugs. 2005;37:415-424.
20. Reid GJ. Pain medication in junior high. Arch Ped Adolesc Med. 1997;151:449-455.
21. Pilitteri JL, Kozlowski LT, Person DC, et al. Over-the-counter sleep aids: widely used by rarely studied. J Subst Abuse 1994;6:315-323.
22. Charlton BG. Self-management and pregnancy-safe interventions for panic, phobia and other anxiety disorders might include over-the-counter (OTC) "SSRI" antihistamines such as diphenhydramine and chlorpheniramine. Acta Psychiatrica Scandinavia. 2005;112:323.
23. Wilson KM, Klein JD, Sesselberg TS, et al. Use of complimentary medicine and dietary supplements among US adolescents. J Adolesc Health. 2006;38:385-394.
24. Fennell D. Determinants of supplement usage. Prev Med. 2004;39:932-939.
25. Haller CA, Benowitz NL, Jacob P, et al. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med. 2005;118:998-1003
26. Bents RT, Tokish JM, Goldberg L. Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players. Phys Sportsmed. 2004;32:30-34.
27. Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatr Serv. 2000;51:1130-1134.
28. Unützer J. Over-the-counter psychotropics. Gen Hosp Psychiatry. 2000;22:221-223.
29. Van Rijswijk E, van de Lisdonk E, Zitman FG. Who uses over-the-counter psychotropics? Characteristics, functioning, and health profile. Gen Hosp Psychiatry. 2000;22:236-241.
30. Hart KE, Hill AL. Generalized use of over-the-counter analgesics: relationship to premenstrual symptoms. J Clin Psychol. 1997;53:197-200.
31. Gravetter FJ, Wallnau LB. Statistics for the Behavioral Sciences. 7th ed. Belmont, CA: Thomson Wadsworth; 2007.
32. Keith TZ. Multiple Regression and Beyond. Boston, MA: Allyn & Bacon; 2005.
33. Dusselier L, Dunn B, Wang Y, et al. Personal, health, academic, and environmental predictors of stress for residence hall students. J Am Coll Health. 2005;54:15-24.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA; 1994.